HOME >> MEDICINE >> NEWS
Prenatal multivitamins for undernourished women may reduce risk of low birth weight

Undernourished women who take a vitamin and mineral supplement while pregnant may be less likely than women taking only iron and folic acid supplements to have babies weighing less than 2,500 grams, and their newborns may be less likely to have morbidity in the first seven days of life, according to a report in the January issue of Archives of Pediatrics & Adolescent Medicine, one of the JAMA/Archives journals.

Low birth weight, or a weight of less than 2,500 grams, is a major predictor of death in infancy, according to background information in the article. It also increases the risk that the child will grow up to develop coronary heart disease, type 2 diabetes, stroke or high blood pressure. In countries low on resources, a mother's nutrition before and during pregnancy are known to affect the birth weight of her baby. Low-income women are often deficient in a number of micronutrients (vitamins and minerals), including vitamins C and E, vitamin B complex and folate.

Piyush Gupta, M.D., M.A.M.S., University College of Medical Sciences, Delhi, India, and colleagues conducted a randomized trial involving 200 women who were 24 to 32 weeks pregnant and either underweight (having a body mass index of less than 18.5) or with a low hemoglobin level (between 7 and 9 grams per deciliter), which can indicate malnourishment. The women all lived within 5 kilometers of a hospital in East Delhi, India, and planned to deliver either at the hospital or in the neighborhood. Information about the participants, including age, height and pre-pregnancy weight, was collected at the hospital between May 1, 2002, and April 30, 2003.

One hundred and one of the women were randomly assigned to take a placebo tablet containing only calcium, and the other 99 received a tablet containing a mix of 29 micronutrients and were instructed to take it daily. Both groups were given iron and folic acid supplements and guidance on prenatal health and were monitore
'"/>

Contact: Piyush Gupta
drpiyush@satyam.net.in
JAMA and Archives Journals
1-Jan-2007


Page: 1 2

Related medicine news :

1. Prenatal cocaine exposure not linked to bad behavior in kids
2. Prenatal alcohol exposure can alter circadian rhythms in offspring
3. Prenatal exposure to famine increases risk of schizophrenia
4. Prenatal sonography has no effect on the intellectual capacity of the developing child
5. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
6. Some women benefit more from exercise when emphasis is on health, not appearance
7. Even older women at high risk have little interest in being tested for HIV, study finds
8. In women, caffeine may protect memory
9. Why women get more migraines than men
10. Hot flashes may be welcome sign in women with breast cancer, study says
11. Study finds difference in survival rates among white and black women with advanced breast cancer

Post Your Comments:
(Date:5/21/2013)... Colo. (May 21, 2013) Research into genetic features ... University of Colorado School of Medicine may lead to ... a paper published online by JAMA . , ... predict survival in some cases of pulmonary fibrosis, a ... years. As a result of the study, researchers may ...
(Date:5/21/2013)... May 21, 2013 The Las Vegas personal ... to announce that Crawford Gates, a senior at Coronado High ... college scholarship essay contest . As the winner of the ... essay contest started on Dec. 1, 2012 and ran through ... to submit a three-page minimum essay on “The Role of ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 While ... is synonymous with comprehensive travel guides. Brunswick Plantation & ... golf packages that include access to 27 holes of ... golf courses in North Carolina, knowing the Top ... and Lodges takes away the overwhelming task of selecting ...
(Date:5/21/2013)... Aggressive treatment for prostate cancer may not be ... conditions, a new study finds. Treatments for ... seed implants, can cause serious side effects, such ... explained researchers from the University of California, Los ... patients with slower growing forms of prostate cancer ...
(Date:5/21/2013)... as 35 percent of Mexican young adults may have ... Illinois scientist who conducted a study at the Universidad ... inherited genetic risk factors from both parents were already ... waist than those who hadn,t. They also had slightly ... of I professor of food science and human nutrition. ...
Breaking Medicine News(10 mins):Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Benson, Bertoldo, Baker & Carter is Pleased to Announce the Winner of its First Annual College Scholarship Essay Contest 2Health News:Brunswick Plantation & Golf Resort Named in Top 10 Golf Resorts in North Carolina 2Health News:Age, Other Illnesses May Make Prostate Cancer Treatment Unnecessary 2Health News:Genetic risk for obesity found in many Mexican young adults 2
(Date:5/21/2013)... , May 21, 2013  Janssen R&D ... results from the global Phase 3 PROMISE study ... simeprevir (TMC435) led to sustained virologic response 12 ... 79 percent of treatment-experienced genotype 1 chronic hepatitis ... all stages of liver fibrosis, when administered once ...
(Date:5/21/2013)... 21, 2013 Abaxis, Inc. (NasdaqGS: ABAX), a ... today that Martin Mulroy , chief ... Dental & Veterinary Conference on Wednesday, May 29, 2013 ... at Le Parker Meridien Hotel in New ... Abaxis develops, manufactures, markets and sells portable blood ...
(Date:5/21/2013)... -- BioRestorative Therapies, Inc. ("BRT" or the "Company") (OTC BB: ... cell based therapies for various personal applications, announced that ... CEO, will be presenting at the Marcum MicroCap Conference.   ... Thursday, May 30, 2013 at the Grand Hyatt Hotel, ... City.  Mr. Weinreb,s presentation will take place at 2:30 ...
Breaking Medicine Technology:Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
Cached News: